Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Brass Adopt Plan to Sell Millions of Shares

NEW YORK (GenomeWeb News) — Certain top executives of newly created Thermo Fisher Scientific have adopted a plan to unload millions of shares of the company’s stock, the company said today.
 
The firm said Chairman Paul Meister plans to sell up to 2.25 million shares and CEO Marijn Dekkers plans to sell just over 1 million shares. The sale would leave Meister with 2.25 million shares and Dekkers with 2.9 million shares or equivalents.
 
Dekkers would acquire the shares he plans to sell when he exercises a stock option that was granted when he joined Thermo in 2000. The option expires in July 2007.
 
Thermo Fisher Scientific said the plan by Meister, Dekkers, and other “certain executive officers” is based on Securities and Exchange Commission stock-trading rules.
 
As GenomeWeb News reported on Nov. 9, Thermo Electron and Fisher Scientific closed their $10.6 billion merger to create Thermo Fisher Scientific.   
 
Dekkers’ and Meister’s shares amount to around 2 percent of the company’s outstanding shares.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more